Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
QNST
|
David J Pauldine
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,938 Added 5.05% |
-
|
Oct 30
2025 |
|
QNST
|
Andrew T Sheehan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,938 Added 36.0% |
-
|
Oct 30
2025 |
|
QNST
|
Andrew T Sheehan
Director |
BUY
Bona fide gift
|
Indirect | 7,732 Added 0.0% |
-
|
Oct 30
2025 |
|
QNST
|
Andrew T Sheehan
Director |
SELL
Bona fide gift
|
Direct | 7,732 Reduced 43.76% |
-
|
Oct 30
2025 |
|
QNST
|
Matthew Glickman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,938 Added 7.47% |
-
|
Oct 30
2025 |
|
RCUS
|
Juan C. Jaen
President |
SELL
Open market or private sale
|
Indirect | 4,314 Reduced 0.0% |
$87,660
$20.32 p/Share
|
Oct 30
2025 |
|
INSG
|
Stephen J Bye
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,879 Added 50.0% |
-
|
Oct 30
2025 |
|
MEDP
|
Fred B Davenport Jr
Director |
SELL
Open market or private sale
|
Direct | 5,972 Reduced 63.06% |
$3,474,987
$581.88 p/Share
|
Oct 30
2025 |
|
MEDP
|
Fred B Davenport Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,472 Added 40.6% |
$355,895
$54.99 p/Share
|
Oct 30
2025 |
|
QNST
|
Stuart Huizinga
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,938 Added 5.18% |
-
|
Oct 30
2025 |
|
KMI
|
Amy W Chronis
Director |
BUY
Open market or private purchase
|
Direct | 487 Added 1.36% |
$12,788
$26.26 p/Share
|
Oct 30
2025 |
|
ETNB
|
Ra Capital Management, L.P. |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 19,889,683 Reduced 0.0% |
-
|
Oct 30
2025 |
|
QNST
|
Asmau Ahmed
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,938 Added 13.27% |
-
|
Oct 30
2025 |
|
NEM
|
Natascha Viljoen
President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 21,898 Reduced 13.64% |
$1,744,613
$79.67 p/Share
|
Oct 30
2025 |
|
HAYW
|
Kevin D. Brown
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,550 Added 0.23% |
-
|
Oct 30
2025 |
|
MTDR
|
Shelley F Appel
Director |
BUY
Open market or private purchase
|
Direct | 1,555 Added 2.36% |
$62,044
$39.9 p/Share
|
Oct 30
2025 |
|
MTDR
|
Shelley F Appel
Director |
BUY
Open market or private purchase
|
Indirect | 1,784 Added 0.0% |
$71,092
$39.85 p/Share
|
Oct 30
2025 |
|
ABNB
|
Aristotle N Balogh
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 0.31% |
$75,282
$125.47 p/Share
|
Oct 30
2025 |
|
LXU
|
Cheryl Maguire
EVP and CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 5,400 Reduced 2.31% |
$52,650
$9.75 p/Share
|
Oct 30
2025 |
|
RYTM
|
Joseph Shulman
Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 9,748 Reduced 53.39% |
$1,123,359
$115.24 p/Share
|
Oct 30
2025 |
|
RYTM
|
Joseph Shulman
Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,748 Added 34.81% |
$298,873
$30.66 p/Share
|
Oct 30
2025 |
|
HAYW
|
Ronald C Keating
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,235 Added 2.62% |
-
|
Oct 30
2025 |
|
MTDR
|
Glenn W Stetson
EVP-Production |
BUY
Open market or private purchase
|
Direct | 700 Added 0.73% |
$27,965
$39.95 p/Share
|
Oct 30
2025 |
|
HAYW
|
Arthur L Soucy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,235 Added 2.58% |
-
|
Oct 30
2025 |
|
CRDO
|
William Joseph Brennan
Pres & Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 0.0% |
$8,637,500
$172.75 p/Share
|
Oct 30
2025 |
|
CRDO
|
William Joseph Brennan
Pres & Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 18,016 Reduced 5.33% |
$3,112,264
$172.75 p/Share
|
Oct 30
2025 |
|
HAYW
|
Stephen J Felice
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,815 Added 0.52% |
-
|
Oct 30
2025 |
|
MTDR
|
Paul W Harvey
Director |
BUY
Open market or private purchase
|
Indirect | 800 Added 0.0% |
$32,239
$40.3 p/Share
|
Oct 30
2025 |
|
CALX
|
Cory Sindelar
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.55% |
$650,000
$65.0 p/Share
|
Oct 30
2025 |
|
CALX
|
Cory Sindelar
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 10.36% |
$50,500
$5.05 p/Share
|
Oct 30
2025 |
|
MTDR
|
Benjamin T Colodney
VP & Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct | 100 Added 1.01% |
$3,935
$39.35 p/Share
|
Oct 30
2025 |
|
GOOG
|
Frances Arnold |
SELL
Open market or private sale
|
Direct | 112 Reduced 0.62% |
$32,681
$291.8 p/Share
|
Oct 30
2025 |
|
IRDM
|
Matthew J Desch
CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct | 20,000 Added 1.74% |
$346,599
$17.33 p/Share
|
Oct 30
2025 |
|
KFS
|
Kent A Hansen
CFO & EVP |
BUY
Open market or private purchase
|
Direct | 111 Added 0.08% |
$1,562
$14.08 p/Share
|
Oct 30
2025 |
|
PCG
|
Jason M Glickman |
SELL
Open market or private sale
|
Direct | 29,473 Reduced 24.84% |
$470,094
$15.95 p/Share
|
Oct 30
2025 |
|
FOR
|
Kellie L Fischer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,453 Added 50.0% |
-
|
Oct 30
2025 |
|
FOR
|
Samuel R Fuller
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 6.38% |
-
|
Oct 30
2025 |
|
FOR
|
Lisa H. Jamieson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 7.73% |
-
|
Oct 30
2025 |
|
FOR
|
Elizabeth Parmer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 50.0% |
-
|
Oct 30
2025 |
|
FOR
|
George W Seagraves
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,453 Added 50.0% |
-
|
Oct 30
2025 |
|
KFS
|
John Taylor Maloney Fitzgerald
President and CEO |
BUY
Open market or private purchase
|
Direct | 177 Added 0.01% |
$2,492
$14.08 p/Share
|
Oct 30
2025 |
|
ENBP
|
Nicholas D Klein
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 348 Reduced 4.72% |
$7,812
$22.45 p/Share
|
Oct 30
2025 |
|
MIR
|
Brian Schopfer
Chief Financial Officer |
SELL
Bona fide gift
|
Direct | 15,000 Reduced 1.63% |
-
|
Oct 30
2025 |
|
MIR
|
Thomas D Logan
Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 106,188 Reduced 3.07% |
-
|
Oct 30
2025 |
|
AGIO
|
Sarah Gheuens
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 200 Added 0.32% |
$5,002
$25.01 p/Share
|
Oct 30
2025 |
|
AGIO
|
Sarah Gheuens
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.32% |
$8,762
$43.81 p/Share
|
Oct 30
2025 |
|
UCBI
|
Richard Bradshaw
EVP, Chief Banking Officer |
SELL
Bona fide gift
|
Direct | 530 Reduced 0.7% |
-
|
Oct 30
2025 |
|
FISV
|
Lance M Fritz
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 43.32% |
$651,800
$65.18 p/Share
|
Oct 30
2025 |
|
TWST
|
Robert F. Werner
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,016 Reduced 1.95% |
$31,943
$31.44 p/Share
|
Oct 30
2025 |
|
TWST
|
Adam Laponis
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,517 Reduced 4.73% |
$173,454
$31.44 p/Share
|
Oct 30
2025 |